Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BSX Boston Scientific Corp
- Stocks
- Healthcare
- NYSE: BSX
Price (delayed)
$104.37
Market cap
$154.41B
P/E Ratio
75.63
Dividend/share
N/A
EPS
$1.38
Enterprise value
$164.99B
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology,
Highlights
The revenue has increased by 19% YoY and by 4.8% from the previous quarter
Boston Scientific's gross profit has increased by 18% YoY and by 4.9% QoQ
BSX's quick ratio is up by 48% since the previous quarter but it is down by 28% year-on-year
The P/E is 10% below the 5-year quarterly average of 83.1 but 9% above the last 4 quarters average of 68.7
Boston Scientific's debt has increased by 6% YoY and by 5% QoQ
Key stats
What are the main financial stats of BSX
Market
Valuations
Earnings
Shares outstanding
1.48B
Market cap
$154.41B
Enterprise value
$164.99B
Price to earnings (P/E)
75.63
Price to book (P/B)
6.93
Price to sales (P/S)
8.78
EV/EBIT
58.84
EV/EBITDA
40.3
EV/Sales
9.4
Revenue
$17.55B
Gross profit
$12.05B
Operating income
$2.85B
Net income
$2.03B
EBIT
$2.8B
EBITDA
$4.09B
Free cash flow
$3.03B
Per share
Balance sheet
Liquidity
EPS
$1.38
EPS diluted
$1.37
Free cash flow per share
$2.05
Book value per share
$15.05
Revenue per share
$11.88
TBVPS
$10.99
Total assets
$40.14B
Total liabilities
$17.69B
Debt
$11.31B
Equity
$22.21B
Working capital
$2.28B
Debt to equity
0.51
Current ratio
1.45
Quick ratio
0.68
Net debt/EBITDA
2.59
Margins
Efficiency
Dividend
EBITDA margin
23.3%
Gross margin
68.7%
Net margin
11.6%
Operating margin
16.2%
Return on assets
5.3%
Return on equity
9.6%
Return on invested capital
13.9%
Return on capital employed
8%
Return on sales
16%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BSX stock price
How has the Boston Scientific stock price performed over time
Intraday
1.13%
1 week
0.52%
1 month
4.64%
1 year
34.34%
YTD
16.85%
QTD
-2.83%
Financial performance
How have Boston Scientific's revenue and profit performed over time
Revenue
$17.55B
Gross profit
$12.05B
Operating income
$2.85B
Net income
$2.03B
Gross margin
68.7%
Net margin
11.6%
The revenue has increased by 19% YoY and by 4.8% from the previous quarter
Boston Scientific's gross profit has increased by 18% YoY and by 4.9% QoQ
Boston Scientific's operating income has increased by 16% YoY and by 9% from the previous quarter
Boston Scientific's net income has increased by 15% YoY and by 10% QoQ
Price vs fundamentals
How does BSX's price correlate with its fundamentals
Growth
What is Boston Scientific's growth rate over time
Valuation
What is Boston Scientific stock price valuation
P/E
75.63
P/B
6.93
P/S
8.78
EV/EBIT
58.84
EV/EBITDA
40.3
EV/Sales
9.4
The EPS has increased by 15% YoY and by 10% from the previous quarter
The P/E is 10% below the 5-year quarterly average of 83.1 but 9% above the last 4 quarters average of 68.7
The stock's price to book (P/B) is 60% more than its 5-year quarterly average of 4.3 and 12% more than its last 4 quarters average of 6.1
The equity has grown by 11% YoY and by 2% from the previous quarter
BSX's P/S is 47% above its 5-year quarterly average of 5.9 and 10% above its last 4 quarters average of 7.9
The revenue has increased by 19% YoY and by 4.8% from the previous quarter
Efficiency
How efficient is Boston Scientific business performance
The return on assets has grown by 8% since the previous quarter and by 3.9% year-on-year
The return on equity has increased by 7% since the previous quarter and by 3.2% year-on-year
BSX's ROIC is up by 6% YoY and by 5% from the previous quarter
The ROS has increased by 3.2% from the previous quarter but it has decreased by 3% YoY
Dividends
What is BSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BSX.
Financial health
How did Boston Scientific financials performed over time
Boston Scientific's total assets is 127% more than its total liabilities
BSX's quick ratio is up by 48% since the previous quarter but it is down by 28% year-on-year
BSX's current ratio is up by 34% since the previous quarter but it is down by 13% year-on-year
Boston Scientific's debt is 49% lower than its equity
The equity has grown by 11% YoY and by 2% from the previous quarter
Boston Scientific's debt has increased by 6% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.